- Home
- TACOW vs KROS Comparison
TACOW vs KROS Comparison
Compare TACOW & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TACOW
- KROS
- Stock Information
- Founded
- TACOW N/A
- KROS 2015
- Country
- TACOW United States
- KROS United States
- Employees
- TACOW N/A
- KROS N/A
- Industry
- TACOW Blank Checks
- KROS Biotechnology: Pharmaceutical Preparations
- Sector
- TACOW Finance
- KROS Health Care
- Exchange
- TACOW Nasdaq
- KROS Nasdaq
- Market Cap
- TACOW N/A
- KROS 558.9M
- IPO Year
- TACOW 2025
- KROS 2020
- Fundamental
- Price
- TACOW $0.70
- KROS $13.37
- Analyst Decision
- TACOW
- KROS Buy
- Analyst Count
- TACOW 0
- KROS 13
- Target Price
- TACOW N/A
- KROS $20.63
- AVG Volume (30 Days)
- TACOW N/A
- KROS 637.6K
- Earning Date
- TACOW N/A
- KROS 08-06-2025
- Dividend Yield
- TACOW N/A
- KROS N/A
- EPS Growth
- TACOW N/A
- KROS N/A
- EPS
- TACOW N/A
- KROS 0.11
- Revenue
- TACOW N/A
- KROS $214,713,000.00
- Revenue This Year
- TACOW N/A
- KROS $5,006.76
- Revenue Next Year
- TACOW N/A
- KROS N/A
- P/E Ratio
- TACOW N/A
- KROS $123.16
- Revenue Growth
- TACOW N/A
- KROS 91657.70
- 52 Week Low
- TACOW N/A
- KROS $9.12
- 52 Week High
- TACOW N/A
- KROS $72.37
- Technical
- Relative Strength Index (RSI)
- TACOW N/A
- KROS 42.27
- Support Level
- TACOW N/A
- KROS $13.25
- Resistance Level
- TACOW N/A
- KROS $13.99
- Average True Range (ATR)
- TACOW 0.00
- KROS 0.36
- MACD
- TACOW 0.00
- KROS -0.06
- Stochastic Oscillator
- TACOW 0.00
- KROS 20.75
About TACOW Berto Acquisition Corp. Warrant
Berto Acquisition Corp is a blank check company.
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.